126 related articles for article (PubMed ID: 21910802)
1. Colchicine in the management of mucous membrane pemphigoid.
Chaidemenos G; Sidiropoulos T; Katsioula P; Koussidou-Eremondi T
Dermatol Ther; 2011; 24(4):443-5. PubMed ID: 21910802
[TBL] [Abstract][Full Text] [Related]
2. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
4. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
Daoud Y; Amin KG; Mohan K; Ahmed AR
Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
[TBL] [Abstract][Full Text] [Related]
5. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
[TBL] [Abstract][Full Text] [Related]
6. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
Shetty S; Ahmed AR
J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
[TBL] [Abstract][Full Text] [Related]
7. Mucous membrane pemphigoid presenting with isolated esophageal involvement: a case report.
Sallout H; Anhalt GJ; Al-Kawas FH
Gastrointest Endosc; 2000 Sep; 52(3):429-33. PubMed ID: 10968869
[No Abstract] [Full Text] [Related]
8. Low-level laser therapy in the treatment of mucous membrane pemphigoid: a promising procedure.
Yilmaz HG; Kusakci-Seker B; Bayindir H; Tözüm TF
J Periodontol; 2010 Aug; 81(8):1226-30. PubMed ID: 20450370
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of mucous membrane pemphigoid and connective-tissue disease.
Malik M; Gürcan HM; Ahmed AR
Clin Exp Dermatol; 2010 Mar; 35(2):156-9. PubMed ID: 19438545
[TBL] [Abstract][Full Text] [Related]
10. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.
Munyangango EM; Le Roux-Villet C; Doan S; Pascal F; Soued I; Alexandre M; Heller M; Lièvre N; Aucouturier F; Caux F; Laroche L; Prost-Squarcioni C
Br J Dermatol; 2013 Feb; 168(2):381-90. PubMed ID: 22963186
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate therapy for ocular cicatricial pemphigoid.
McCluskey P; Chang JH; Singh R; Wakefield D
Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in mucous membrane pemphigoid.
Daniel E; Thorne JE
Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
[TBL] [Abstract][Full Text] [Related]
15. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches to patients with mucous membrane pemphigoid.
Kourosh AS; Yancey KB
Dermatol Clin; 2011 Oct; 29(4):637-41. PubMed ID: 21925010
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.
Sami N; Bhol KC; Razzaque Ahmed A
Clin Immunol; 2002 Jan; 102(1):59-67. PubMed ID: 11781068
[TBL] [Abstract][Full Text] [Related]
18. [Pemphigoid of the mucous membranes. The clinical, histopathological and immunological aspects and current therapeutic concepts].
Carrozzo M; Broccoletti R; Carbone M; Garzino-Demo P; Gandolfo S
Minerva Stomatol; 1996 Oct; 45(10):455-63. PubMed ID: 9026690
[TBL] [Abstract][Full Text] [Related]
19. Oral mucosal diseases: mucous membrane pemphigoid.
Scully C; Lo Muzio L
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):358-66. PubMed ID: 17804127
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic management of mucous membrane pemphigoid. Report of 11 cases].
Carrozzo M; Carbone M; Broccoletti R; Garzino-Demo P; Gandolfo S
Minerva Stomatol; 1997 Oct; 46(10):553-9. PubMed ID: 9432562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
